# Phathom Pharmaceuticals, Inc.: Form SCHEDULE 13D/A, filed May 13, 2025

- Company: [Phathom Pharmaceuticals, Inc.](/companies/phat.md) (CIK 1783183)
- Form: SCHEDULE 13D/A
- Filed: 2025-05-13
- Accepted by EDGAR: May 13, 2025, 16:22 ET
- Period: not reported
- Accession: 0001415889-25-012779
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1783183/000141588925012779/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1783183/000141588925012779/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1783183/000141588925012779/xslSCHEDULE_13D_X01/primary_doc.xml

Filed May 13, 2025.
Source: SEC EDGAR, the filing index for accession 0001415889-25-012779. Last ingested by Listed: Nov 2, 2026, 17:47 ET. No prices; not investment advice.